Concepedia

Jonathan M. Goodwin

JM

14

Publications

1.8K

Citations

13

H-Index

1996

Active since

Affiliations

Massachusetts General Hospital(Current)

Harvard University

University of Toronto

Novartis Institutes for BioMedical Research

Babraham Institute

Jonathan M. Goodwin is an author at Massachusetts General Hospital specializing in medicine, cell biology, and cell signaling.

ORCID

Top concepts

Publications per year

1996–2022

14

Publications

14

Epithelial-to-Mesenchymal Transition and Integrin-Linked Kinase Mediate Sensitivity to Epidermal Growth Factor Receptor Inhibition in Human Hepatoma Cells

Bryan C. Fuchs, Tsutomu Fujii, Jon D. Dorfman et al. · Cancer Research · 2008 · 307 citations

Epidermal Growth Factor Gene Functional Polymorphism and the Risk of Hepatocellular Carcinoma in Patients With Cirrhosis

Kenneth K. Tanabe, Antoinette Lemoine, Dianne M. Finkelstein et al. · JAMA · 2008 · 208 citations · Full text

Mouse model of carbon tetrachloride induced liver fibrosis: Histopathological changes and expression of CD133 and epidermal growth factor

Tsutomu Fujii, Bryan C. Fuchs, Suguru Yamada et al. · BMC Gastroenterology · 2010 · 191 citations · Full text

Autophagy-Independent Lysosomal Targeting Regulated by ULK1/2-FIP200 and ATG9

Jonathan M. Goodwin, William E. Dowdle, Rowena DeJesus et al. · Cell Reports · 2017 · 184 citations · Full text

<scp>TMEM</scp> 41B is a novel regulator of autophagy and lipid mobilization

Francesca Moretti, Phil Bergman, Stacie E. Dodgson et al. · EMBO Reports · 2018 · 171 citations · Full text

, , +9

Rows per page

1–5 of 14